ANVS - Annovis Bio, Inc.

QQQ $ 482.74 $ 1.62 (0.34 %)

DIA $ 408.91 $ -0.32 (-0.08 %)

SPY $ 560.81 $ 0.88 (0.16 %)

TLT $ 98.72 $ 0.04 (0.04 %)

GLD $ 232.16 $ 0.50 (0.22 %)

Previous Close

$ 8.92

Open

$ 8.97

Bid

$ 9.61 x 100

Ask

-- x --

Day's Range

$ 8.97 - $ 9.64

52 Week Range

$ 4.53 - $ 22.49

Volume

95,976

Average Volume

Market Cap

100.87M

Beta (5Y Monthly)

$ 1.71

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2024	06-30-2024	10-Q
2	05-10-2024	03-31-2024	10-Q
3	03-29-2024	12-31-2023	10-K
4	11-08-2023	09-30-2023	10-Q
5	08-14-2023	06-30-2023	10-Q
6	05-10-2023	03-31-2023	10-Q
7	03-31-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-08-2022	06-30-2022	10-Q
10	05-04-2022	03-31-2022	10-Q
11	03-02-2022	12-31-2021	10-K
12	11-03-2021	09-30-2021	10-Q
13	07-28-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	03-03-2021	12-31-2020	10-K
16	11-04-2020	09-30-2020	10-Q
17	07-29-2020	06-30-2020	10-Q
18	05-05-2020	03-31-2020	10-Q
19	03-25-2020	12-31-2019	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

EF Hutton Maintains Buy on Annovis Bio, Ma...
08/15/2024 20:21:04

EF Hutton analyst Jason Kolbert maintains Annovis Bio (NYSE:ANVS) with a Buy and maintains $21 price target.

HC Wainwright & Co. Reiterates Buy on Anno...
08/15/2024 11:39:41

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Annovis Bio (NYSE:ANVS) with a Buy and maintains $30 price tar...

Annovis Bio Q2 2024 GAAP EPS $(0.44) Misse...
08/15/2024 11:16:38

EF Hutton Initiates Coverage On Annovis Bi...
08/13/2024 11:40:29

EF Hutton analyst Jason Kolbert initiates coverage on Annovis Bio (NYSE:ANVS) with a Buy rating and announces Price Target o...

Annovis Announces Preclinical Data Demonst...
08/06/2024 12:04:44

Annovis Bio Secures U.S. Patent For Treatm...
07/24/2024 12:07:42

Annovis Bio Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneeri...

HC Wainwright & Co. Reiterates Buy on Anno...
07/17/2024 10:35:58

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Annovis Bio (NYSE:ANVS) with a Buy and maintains $30 price tar...

Annovis Bio Granted FDA Approval To Transi...
07/16/2024 12:00:56

costco-to-rally-more-than-10-here-are-10-top-analyst-forecasts-for-thursday

Costco To Rally More Than 10%? Here Are 10...
07/11/2024 12:47:29

HC Wainwright & Co. Maintains Buy on Annov...
07/11/2024 11:45:36

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Annovis Bio (NYSE:ANVS) with a Buy and raises the price target ...

why-seastar-medical-holding-shares-are-trading-lower-by-around-34-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why SeaStar Medical Holding Shares Are Tra...
07/10/2024 17:18:59

Annovis Bio Shares Resume Trade
07/09/2024 13:39:59

Annovis Shares Halted On Circuit Breaker T...
07/09/2024 13:35:44

why-nio-shares-are-trading-lower-by-over-8-here-are-other-stocks-moving-in-fridays-mid-day-session

Why NIO Shares Are Trading Lower By Over 8...
07/05/2024 16:59:40

Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has res...

peering-into-annovis-bios-recent-short-interest

Peering Into Annovis Bio's Recent Short In...
07/03/2024 19:00:19

What's Going On With Annovis Shares Today?
07/03/2024 11:12:32

Annovis Bio shares rise in premarket trading on positive Phase III Parkinson's study results for buntanetap, showing cognit...

tesla-paramount-global-annovis-bio-eli-lilly-amazon-why-these-5-stocks-are-on-investors-radars-today

Tesla, Paramount Global, Annovis Bio, Eli ...
07/03/2024 03:38:25

On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in p...

Annovis Bio Shares Halted On Circuit Break...
07/02/2024 17:27:09

Rodman & Renshaw Reiterates Buy on Annovis...
07/02/2024 16:46:56

Rodman & Renshaw analyst Elemer Piros reiterates Annovis Bio (NYSE:ANVS) with a Buy and maintains $67 price target.

What's Going With Annovis Bio Shares Tuesday?
07/02/2024 15:48:30

Annovis announced new data from its Phase III Parkinson's study. The study showed improvements on the Unified Parkinson'...